We have a new webinar coming up this month, and news to share about new technologies and models available at TransCure bioServices. We're looking forward to working with you in 2023!
TransCure bioServices has recently developed new mouse models for studying cancer therapies against Acute myeloid leukemia (AML) in vivo. These mouse leukemia models represent a great advance in preclinical research against this aggressive form of cancer.
Developed in collaboration with the pharmaceutical industry and academic institutes, BioVolume is the world’s first 3D imaging solution. It enables the measurement and visualization of tumor growth in 3D animal models in preclinical research, oncology, and drug development.
Follow us and share this newsletter on LinkedIn and Twitter
TransCure bioServices, Biopark, Le Forum 1, 260, av. Marie Curie, Archamps, France 74160, +33 4 57 62 83 79
